Articles From: LAWSUIT ALERT: The Law Firm of Andrews & Springer LLC Announces That a Securities Fraud Class Action Has Been Filed by a Law Firm Against EZCORP, Inc. -- EZPW to Omnitracs to Acquire XRS Corporation


MARLBOROUGH, Mass.
Sign-up for Boston Scientific Closes Acquisition Of Interventional Business Of Bayer AG investment picks
LYNBROOK, N.Y. , Sept.
Sign-up for BioSpecifics Technologies Corp. Announces Presentations at Upcoming Investor Conferences investment picks
SFX Entertainment, Inc. (NASDAQ:SFXE) (“SFX”) announced today that it has extended the expiration date of its previously announced consent solicitation (the “Solicitation”) to a proposed amendment (the “Proposed Amendment”) to the indenture (the “Indenture”) governing its outstanding 9.625% Second Lien Senior Secured Notes due 2019 (the "Securities"). The Solicitation will now expire at 5:00 p.m., New York City time, on September 5, 2014, unless further extended (as extended, the “Expiration Time”). The full terms of the Solicitation are detailed in SFX’s consent solicitation statement (the “Statement”) and related consent form, each dated as of August 19, 2014.
Sign-up for SFX Entertainment, Inc. Announces Extension of Consent Solicitation Relating to Its 9.625% Second Lien Senior Secured Notes Due 2019 investment picks
DUBLIN , Sept.
Sign-up for FLY Leasing Acquires Two Airbus A330-300 Aircraft investment picks
Kyungpook National University Hospital in South Korea Treats the First Patient in the 14 Country, 100 Site Global Study Study Designed to Support Registration in Major Liver Cancer Markets Worldwide LAWRENCEVILLE, N.J. , Sept.
Sign-up for Celsion Announces Enrollment of First Patient in Global Phase III OPTIMA Study of ThermoDox® in Primary Liver Cancer investment picks
VICTORIA, B.C., Sept.
Sign-up for Aurinia Pharmaceuticals to Begin Trading on the NASDAQ Global Market investment picks
Sophiris Bio Inc. (NASDAQ: SPHS) (the “Company” or “Sophiris”), a biopharmaceutical company developing PRX302 (topsalysin) for the treatment of the symptoms of benign prostatic hyperplasia (BPH, enlarged prostate) and for the treatment of localized prostate cancer, today announced that it has fully enrolled its ongoing Phase 3 trial (referred to as PLUS-1) of PRX302 as a treatment for lower urinary tract symptoms of BPH.
Sign-up for Sophiris Bio Reports Completion of Enrollment in the "PLUS-1" Phase 3 Trial of PRX302 for Benign Prostatic Hyperplasia investment picks
-- Company to Provide Updated Fiscal 2015 Guidance, Insight into Fiscal 2016 and Customer Updates --
Sign-up for Mandalay Digital to Host Investor Call at 4:30 pm ET on September 9 investment picks
SAN DIEGO , Sept.
Sign-up for InfoSonics Reveals Its First LTE Smartphone: the verykool® SL5000 'Quantum' investment picks
Veeco Instruments Inc. (Nasdaq:VECO) today announced that management is scheduled to participate in the following investor conferences: Tuesday, September 9, 2014 at 10:20AM PT at the Deutsche Bank Technology Conference at the Cosmopolitan Hotel in Las Vegas, NV.
Sign-up for Veeco to Participate in Upcoming Investor Conferences investment picks
Splunk Inc. (NASDAQ: SPLK), provider of the leading software platform for real-time Operational Intelligence, today announced that Amaya Gaming , provider of a full suite of online gaming products and services, has transformed its development approach and enhanced performance across its online properties with the help of Splunk® Enterprise.
Sign-up for Amaya Gaming Gains Operational Intelligence Across its Global Websites with Splunk Software investment picks
Spok Holdings, Inc. (NASDAQ:SPOK), formerly USA Mobility, Inc., a global leader in critical communications , today named Danielle Brogan as Controller and Chief Accounting Officer.
Sign-up for Spok Names Brogan Controller and Chief Accounting Officer investment picks
CE Series school bus pairs PSI 8.8-liter propane engine and Allison transmission to maximize power, torque, durability and efficiency LISLE, Ill.
Sign-up for IC Bus Adds Purpose-Built Propane School Bus Offering investment picks
NephroGenex, Inc. (NASDAQ:NRX), a pharmaceutical company focused on the development of therapeutics to treat kidney disease, today announced that Chief Executive Officer, Pierre Legault will present an overview of the Company and meet with investors at four healthcare conferences for institutional investors in September.
Sign-up for NephroGenex To Participate in Four Healthcare Conferences in September investment picks
Awarding-Winning Loyalty Program Offers Free Enrollment, Easier Status Upgrades, Faster Rentals and More Rewards NAPLES, Fla.
Sign-up for Hertz Celebrates Three Years Of Industry-Leading Gold Plus Rewards Program investment picks
COFFEYVILLE, Kan.
Sign-up for CVR Refining's Coffeyville Refinery Resumes Normal Operations investment picks
CHARLOTTE, N.C., Sept.
Sign-up for Swisher Announces Closing of New $20 Million Revolving Credit Facility investment picks
Urges Shareholders to Vote Today FOR ALL CONMED's Director Nominees on the GOLD Proxy Card UTICA, N.Y., Sept.
Sign-up for CONMED Corporation Issues Open Letter to Shareholders investment picks
BEIJING, Sept.
Sign-up for 21Vianet Announces US$5 Million Share Repurchase Program investment picks
Represents First Marketing Authorization Application in the European Union for a PCSK9 Inhibitor THOUSAND OAKS, Calif.
Sign-up for Amgen Submits Marketing Authorization Application For Novel Investigational LDL Cholesterol-Lowering Medication Evolocumab To The European Medicines Agency investment picks
Allergan, Inc. (NYSE: AGN) announced today that the European Commission has extended the Marketing Authorization for OZURDEX ® (dexamethasone 700 mcg intravitreal implant in applicator) to treat adult patients with visual impairment due to diabetic macular edema (DME) who are pseudophakic (have an artificial lens implant), or who are considered insufficiently responsive to, or unsuitable for non-corticosteroids therapy.
Sign-up for Allergan Announces OZURDEX® (dexamethasone 700 mcg intravitreal implant in applicator) Now Approved in the European Union for the Treatment of Diabetic Macular Edema investment picks
SONIC® Drive-In (NASDAQ:SONC) today announced the launch of its new line of Waffle Cone Sundaes, offering guests even more ways to enjoy SONIC’s Real Ice Cream offerings.
Sign-up for SONIC Introduces New Waffle Cone Sundaes to Frozen Dessert Menu investment picks
SONIC® Drive-In (NASDAQ:SONC) continues to build its variety of premium chicken menu items with the introduction of the new Cheesy Pub Chicken Sandwich.
Sign-up for SONIC Infuses Fresh, Unique Flavors in Chicken Lineup with New Cheesy Pub Chicken Sandwich investment picks
- Patent Protection for NB32 for Treating Insulin Resistance - SAN DIEGO , Sept.
Sign-up for Orexigen Expands NB32 Intellectual Property Portfolio With New U.S. Patent investment picks
Pacific Insight Electronics Corp.
Sign-up for Pacific Insight Electronics Corp. agrees to credit facilities of $22 million investment picks
Agreement Exemplifies and Strengthens Omnitracs' Commitment to Leading the Transportation and Logistics Technology Market SAN DIEGO , Sept.
Sign-up for Omnitracs to Acquire XRS Corporation investment picks
Omnitracs to Acquire XRS Corporation Canada NewsWire Agreement Exemplifies and Strengthens Omnitracs' Commitment to Leading the Transportation and Logistics Technology Market SAN DIEGO , Sept.
Sign-up for Omnitracs to Acquire XRS Corporation investment picks
Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: LAWSUIT ALERT: The Law Firm of Andrews & Springer LLC Announces That a Securities Fraud Class Action Has Been Filed by a Law Firm Against EZCORP, Inc. -- EZPW to Omnitracs to Acquire XRS Corporation
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices